Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844246 · ClinicalTrials.gov registry record · Phase 2
Translating Evidence Based Developmental Screening Into Pediatric Primary Care
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,314
- Enrollment target
NCT00844246: Completed Phase 2 study, sponsored by Children's Hospital of Philadelphia.
NCT00844246 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 2,314 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1640% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00844246, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,314 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age.
Interventions
- OTHER Developmental screening using ASQ and MCHAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,314 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
What the finished NCT00844246 record still lists
NCT00844246 is an interventional study that assigns participants to a tested intervention. Its 2,314 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1640% higher).
The record links to 0 conditions, and to 1 intervention - of which Developmental screening using ASQ and MCHAT is the first listed.
NCT00844246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00844246 about?
NCT00844246 is a clinical study titled "Translating Evidence Based Developmental Screening Into Pediatric Primary Care". The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical development...
What is the current status of trial NCT00844246?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,314 participants. The study started on 2008-11. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00844246?
The interventions under investigation include: Developmental screening using ASQ and MCHAT (OTHER).
Who is sponsoring clinical trial NCT00844246?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00844246's enrollment target sits among peer trials
2,314 8th of 2000 higher than 1,993 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05485961 · 2,310 participants · Phase 2
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia